Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valli De Re

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Hepatitis Monthly|February 7, 2012
Interferon-based therapy for chronic hepatitis C: current and future perspectivesValli De Re
International Journal of Molecular Sciences|October 14, 2018
Molecular Features Distinguish Gastric Cancer SubtypesValli De Re
Annals of the New York Academy of Sciences|August 24, 2017
Coagulation and fibrinolysis in gastric cancerOmbretta Repetto, Valli De Re
Proteomics. Clinical Applications|December 8, 2010
Hepatitis C virus-induced oxidative stress and mitochondrial dysfunction: a focus on recent advances in proteomicsMaria Paola Simula, Valli De Re
Expert Opinion on Therapeutic Targets|December 14, 2023
How will the identification and therapeutic intervention of genetic targets in oncology evolve for future therapy?Paolo Baldo, Valli De Re, Mattia Garutti
Leukemia & Lymphoma|August 3, 2002
Hepatitis C virus, B-cell proliferation and lymphomasDaniela Gasparotto, Valli De Re, Mauro Boiocchi
Frontiers in Medicine|September 16, 2017
New Insights into the Pathogenesis of Celiac DiseaseValli De Re, Raffaella Magris, Renato Cannizzaro
International Journal of Molecular Sciences|May 31, 2018
Immunotherapy for Gastric Cancer: Time for a Personalized Approach?Riccardo Dolcetti, Valli De Re, Vincenzo Canzonieri
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 11, 2021
Biomarkers and OLGIM Stage for Prospective Preneoplastic Risk StratificationValli De Re, Roberto Vettori, Renato Cannizzaro
Clinical Biochemistry|November 13, 2012
The versatile role of gliadin peptides in celiac diseaseValli De Re, Laura Caggiari, Maria Tabuso, et al.
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Hepatitis Monthly|February 7, 2012
Interferon-based therapy for chronic hepatitis C: current and future perspectivesValli De Re
International Journal of Molecular Sciences|October 14, 2018
Molecular Features Distinguish Gastric Cancer SubtypesValli De Re
Annals of the New York Academy of Sciences|August 24, 2017
Coagulation and fibrinolysis in gastric cancerOmbretta Repetto, Valli De Re
Proteomics. Clinical Applications|December 8, 2010
Hepatitis C virus-induced oxidative stress and mitochondrial dysfunction: a focus on recent advances in proteomicsMaria Paola Simula, Valli De Re
Expert Opinion on Therapeutic Targets|December 14, 2023
How will the identification and therapeutic intervention of genetic targets in oncology evolve for future therapy?Paolo Baldo, Valli De Re, Mattia Garutti
Leukemia & Lymphoma|August 3, 2002
Hepatitis C virus, B-cell proliferation and lymphomasDaniela Gasparotto, Valli De Re, Mauro Boiocchi
Frontiers in Medicine|September 16, 2017
New Insights into the Pathogenesis of Celiac DiseaseValli De Re, Raffaella Magris, Renato Cannizzaro
International Journal of Molecular Sciences|May 31, 2018
Immunotherapy for Gastric Cancer: Time for a Personalized Approach?Riccardo Dolcetti, Valli De Re, Vincenzo Canzonieri
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 11, 2021
Biomarkers and OLGIM Stage for Prospective Preneoplastic Risk StratificationValli De Re, Roberto Vettori, Renato Cannizzaro
Clinical Biochemistry|November 13, 2012
The versatile role of gliadin peptides in celiac diseaseValli De Re, Laura Caggiari, Maria Tabuso, et al.
Pageof 14